Victor Sandor, MD: ARRY 797 As a Specific Therapy for Dilated Cardiomyopathy?

Victor Sandor, MD, Array BioPharma, shared results from ARRY 797 study at the European Society of Cardiology Congress 2016. Sandor also explained the necessity in open, more mainstream dialogue about LMNA-related DCM patients to further the known research. "We're very excited by these results. We think that even though it's a relatively small study, the consistency of data over several different endpoints makes us fairly confident that there's really something here and it's going to be a big advantage to these patients who really, at this point, have no alternative," concluded Sandor.